Correspondent Profile

National Correspondent Name:  Marcos Daquinta Gradaille
Profile Picture:
Country:  Cuba
Organisation:  Centro de Bioplantas
Number of Members:  1
IAPB related activities if any that you organise within your country/region e.g local meetings:  Congress of Biotechnology Bioveg
Conferences/events/meetings that you plan on attending this year or early next year: Bioveg 2017 and XIII Symposium of Plant Biotechnology (2018)
A short piece about the plant science sector/industry in your country:
The social impact of Cuban biotechnological products can be found in vaccine safety and its impact on the population such as Meningitis B / C and Hepatitis B; Diagnostic technologies and drugs dedicated to fighting viral diseases, myocardial infarction, rejection of organ transplants, to name a few. Currently, short, medium and long term bivalent, trivalent, tetravalent and pentavalent vaccines are being used in a vaccine candidate against dengue, in two other vaccines to combat AIDS, which prolongs the onset of the disease in those already Infected with the virus, and in preventive variants. In plant biotechnology, we are working hard to create a new generation of bioproducts, transgenic plants resistant to biotic and abiotic stress (pests, diseases, droughts and salinity), although none have yet been obtained. Likewise, researchers are working to achieve plants of higher nutritional value (nutraceuticals) and plant dynamics that have no adverse affects on human health and the environment. In the case of animal biotechnology, the greatest impact has been on the above bovine tick vaccine.